Complete

A new way to diagnose and prevent squamous cell carcinoma

Cancer types:

Skin cancer

Project period:

Research institute:

New York University

Award amount:

£194,081

Location:

USA

Researcher Dr Markus Schober

Dr Markus Schober aims to work out how cells rewire their internal programs into a state that helps them turn into cancer cells. 

Meet the scientist

Markus is Assistant Professor in the Department of Biology at New York University in the United States. His expertise in understanding how cancer cells function has led to key discoveries.

The science

Squamous cell carcinoma (SCC) is a group of cancers that originate in cells forming the surface of the skin and lining the internal walls of our organs, respiratory tract and digestive tract. Collectively, these cancers represent the second largest number of cancers worldwide. Many of these cancers are treated successfully in the early stages of the disease, but if diagnosed late, SCC can be much more aggressive and difficult to treat. 

Dr Markus Schober is uncovering the molecular secrets that allow healthy cells to make the switch to becoming SCC cells. Once revealed, this knowledge could lead to new ways to improve the early diagnosis and prevention of SCC. 

Related projects

Complete USA

Skin cancer

How do some skin cancer cells become resistant to treatment?

This project hopes to discover how skin cancer develops resistance to treatments and find ways to overcome it so that survival rates improve.

Researcher: Dr Bin Zheng

Overcoming drug resistance in skin cancer
Lesley Stark Headshot

Active United Kingdom

Bowel cancer

Journey to the centre of a cell: why does age matter in cancer?

With your support, Professor Lesley Stark and her team in Edinburgh hope to find new ways to prevent cancer linked to ageing. This has huge potential to reveal new approaches to cancer treatment or to prevent it developing in older people. 

Researcher: Professor Lesley Stark

Journey to the centre of a cell: why does age matter in cancer?
Ruud Delwel Headshot

Active Netherlands

Leukaemia

Mission impossible: how can we target “Evi1” leukaemias?

Thanks to our Curestarters, Professor Delwel and his team in the Netherlands hope to find a much-needed new leukaemia cure. Acute Myeloid Leukaemia (AML) can sometimes be caused by a specific gene, so by better understanding this gene we can look for new cures. 

 

Researcher: Professor Ruud Delwel

Mission impossible: how can we target “Evi1” leukaemias?
Share this page